Lung Cancer: Research
The question
To ask the Secretary of State for Health and Social Care, what steps he is taking to support research on (a) the causes of and (b) treatments for metastatic lung cancer.
Answered by Andrew Gwynne
Research is crucial in tackling cancer, which is why the Department invests over £1.5 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23. The NIHR spends more on cancer than any other disease group, reflecting its high priority.
The NIHR also invests in research infrastructure to support the delivery of research. This includes research into a novel cancer vaccine for lung cancer patients that primes the immune system to recognise and fight cancer cells.
The NIHR welcomes funding applications for research into any aspect of human health, including lung cancer. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. The NIHR welcomes further high-quality proposals to understand the causes of and to inform approaches to treating metastatic lung cancer.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →